迫近骨折风险:机制、评估与治疗启示
本综述讨论骨质疏松中「迫近骨折风险」概念,指初次脆性骨折后通常12至24个月内再次骨折概率急剧升高,且风险在伤后前3至6个月达峰。传统评估多关注10年长期风险,可能延误高危期治疗;识别迫近风险有助于尽早药物干预、阻断骨折级联。
要点
- 迫近骨折风险指初次骨折后12至24个月内再骨折概率急剧升高。
- 再骨折风险在伤后前3至6个月显著达峰,并非均匀分布。
- 传统10年风险评估可能延误高危窗口期的早期治疗。
核心结论
- 识别迫近骨折风险可提示临床紧迫性,支持早期治疗以快速降低再骨折风险。
研究设计与样本
- 本文为综述,围绕迫近骨折风险的机制、风险评估与治疗启示进行讨论。
主要发现
- 既往骨折是未来骨折的主要预测因素,但风险并不均匀,伤后前3至6个月显著达峰。
- 迫近风险通常指初次哨兵骨折后12至24个月内再发脆性骨折概率急剧升高。
关键数值与推荐
- 迫近骨折风险的时间窗通常为初次骨折后12至24个月。
- 再骨折风险在伤后前3至6个月显著达峰。
临床怎么用
- 对近期发生脆性骨折者应识别迫近风险,尽早启动药物干预以阻断骨折级联。
- 不应仅依赖10年长期风险预测而延误高危窗口期的治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Identifying imminent fracture risk is a critical opportunity to manage osteoporosis. This term refers to the sharply elevated probability of sustaining a subsequent fragility fracture within a determined period-typically 12 to 24 months-after an initial sentinel fracture. While a prior fracture is widely recognized as a primary predictor of future events, epidemiological data show that this risk is not uniform; rather, it peaks significantly within the first 3 to 6 months after injury. This review discusses a significant clinical gap: traditional assessment tools often focus on long-term, 10-year risk projections, which may delay treatment during this high-vulnerability period. Recognizing imminent risk highlights clinical urgency, indicating the need for early use of therapeutic interventions to rapidly reduce the risk of further fractures. Identifying patients at imminent risk offers an opportunity for secondary prevention, promoting immediate pharmacological action to interrupt the "fracture cascade" and enhance long-term skeletal health.
引用
- Vilaca T, Eastell R. Imminent fracture risk: contributing mechanisms, risk assessment, and implications for treatment. J Clin Endocrinol Metab. 2026. PMID: 42444566. doi:10.1210/clinem/dgag278
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。